Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print April 4, 2008
DOI: 10.2337/db08-0276

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db08-0276v1
db08-0276v2
57/7/1905    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossetti, P.
Right arrow Articles by Fanelli, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossetti, P.
Right arrow Articles by Fanelli, C. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

EFFECT OF ORAL AMINO ACID ON COUNTERREGULATORY RESPONSES AND COGNITIVE FUNCTION DURING INSULIN-INDUCED HYPOGLYCEMIA IN NON-DIABETIC AND TYPE 1 DIABETIC PEOPLE

Paolo Rossetti, MD, Francesca Porcellati, MD, PhD, Natalia Busciantella Ricci, MD, Paola Candeloro, PhD, Patrizia Cioli, RD, K. Sreekumaran Nair, MD, Fausto Santeusanio, MD, Geremia B. Bolli, MD, and Carmine G. Fanelli, MD, PhD

Department of Internal Medicine, University of Perugia, Perugia, Italy

Objective: Amino acids (AA) stimulate glucagon responses to hypoglycaemia, and may be utilized by the brain. Aim of study was to assess the responses to hypoglycemia in nondiabetic and type 1 diabetic subjects after ingestion of AA mixture.

Research Design and Methods: 10 nondiabetic and 10 diabetic type 1 subjects were studied on three different occasions during intravenous insulin (2 mU/kg/min) + variable glucose for 160 minutes. In two studies, clamped hypoglycemia (plasma glucose 47 mg/dl for 40 min) was induced and either oral placebo (P) or AA mixture (42g) was given at +30 min. In the third study AA were given, but euglycemia was maintained.

Results: Plasma glucose and insulin were no different in the hypoglycemia studies both with P and AA (p>0.2). After AA, plasma AA concentration increased to levels observed after mixed meal (2.4±0.13 vs P study 1.7±0.1 mmol/l, p=0.02). During clamped euglycemia, AA resulted in transient increase in glucagon concentrations, which returned to basal by the end of study. During clamped hypoglycemia, glucagon response was sustained and increased more in AA studies vs P in nondiabetics and diabetics (p<0.05), but other counterregulatory hormones and total symptom score were not different. Beta-OH-butyrate was less suppressed after AA (200±15 vs 93±9 µmol/L, p=0.01). Among the cognitive tests administered, the following indicated less deterioration after AA than P: Trail-making B, PASAT (2 sec), Digit span forward, Stroop colored words and verbal memory tests (nondiabetics), and Trail-Making B, Digit span backwards and Stroop color tests (diabetics).

Conclusions: Oral amino acids improve cognitive function in response to hypoglycemia, and enhance the response of glucagon in nondiabetic and in diabetic subjects.


Correspondence: gbolli{at}unipg.it

Key Words: Type 1 Diabetes • hypoglycemia • glucagon secretion • amino acid • cognitive function


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.